ReviewVaccine2015
Enhancing vaccine safety capacity globally: A lifecycle perspective.
Review in Vaccine, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 27 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
27 citing papers in PubMed.
- Longitudinal Meta-cohort study protocol using systems biology to identify vaccine safety biomarkers.Vaccine · 2025Article
- Article
- Pharmacovigilance-based 12-year post-marketing safety analysis of quadrivalent influenza vaccines in children: a VAERS surveillance study.Frontiers in pediatrics · 2025Article
- Review
- System and facility readiness assessment for conducting active surveillance of adverse events following immunization in Addis Ababa, Ethiopia.International health · 2023Article
- Documenting capacity and existing gaps in reporting adverse events following immunisation in Northern Ghana: a quantitative cross-sectional survey of healthcare workers.BMJ public health · 2023Article
- Review
- Construction and validity of an educational video to prevent immunization errors.Revista brasileira de enfermagem · 2023Article
- Efficacy and Safety of COVID-19 Vaccination in Older Adults: A Systematic Review and Meta-Analysis.Vaccines · 2022Review
- A Traceable Vaccine Supply Management System.Sensors (Basel, Switzerland) · 2022Article
- Vaccine Adverse Event Mining of Twitter Conversations: 2-Phase Classification Study.JMIR medical informatics · 2022Article
- Optimising reporting of adverse events following immunisation by healthcare workers in Ghana: A qualitative study in four regions.PloS one · 2022Article
- Article
- Tracking the progress in COVID-19 and vaccine safety research - a comprehensive bibliometric analysis of publications indexed in Scopus database.Human vaccines & immunotherapeutics · 2021Article
- Advancing sustainable development goals through immunization: a literature review.Globalization and health · 2021Review
- Review
- A Prospective Cohort Study on the Safety of Infant Pentavalent (DTwP-HBV-Hib) and Oral Polio Vaccines in Two South Indian Districts.The Pediatric infectious disease journal · 2020Article
- Barriers to healthcare workers reporting adverse events following immunization in four regions of Ghana.Vaccine · 2020Article
- A self-aggregating peptide: implications for the development of thermostable vaccine candidates.BMC biotechnology · 2020Article
- Retrospective study of immunization errors reported in an online Information System.Revista latino-americana de enfermagem · 2020Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
Major vaccine safety controversies have arisen in several countries beginning in the last decades of 20th century. Such periodic vaccine safety controversies are unlikely to go away in the near future as more national immunization programs mature with near elimination of target vaccine-preventable diseases that result in relative greater prominence of adverse events following immunizations, both true reactions and temporally coincidental events. There are several ways in which vaccine safety capacity can be improved to potentially mitigate the impact of future vaccine safety controversies. This paper aims to take a "lifecycle" approach, examining some potential pre- and post-licensure opportunities to improve vaccine safety, in both developed (specifically U.S. and Europe) and low- and middle-income countries.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.